Life Healthcare Group Holdings Future Growth
Future criteria checks 1/6
Life Healthcare Group Holdings is forecast to grow earnings and revenue by 7.5% and 5% per annum respectively. EPS is expected to grow by 6.7% per annum. Return on equity is forecast to be 17.2% in 3 years.
Key information
7.5%
Earnings growth rate
6.7%
EPS growth rate
Healthcare earnings growth | 26.1% |
Revenue growth rate | 5.0% |
Future return on equity | 17.2% |
Analyst coverage | Good |
Last updated | 23 Jan 2025 |
Recent future growth updates
Recent updates
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Aug 05Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17
May 30Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital
Apr 20Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Mar 18Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends
Dec 24We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings
Nov 24Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25
Nov 23An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued
Sep 14Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Aug 15Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)
Jul 31Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?
May 19Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital
Apr 28An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued
Feb 08There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Jan 25With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For
Jan 08Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?
Nov 28Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?
Oct 19Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return
Aug 16We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt
Jul 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2027 | 30,053 | 2,528 | 704 | 4,033 | 4 |
9/30/2026 | 28,190 | 2,076 | 1,061 | 4,168 | 7 |
9/30/2025 | 26,769 | 1,967 | 788 | 3,920 | 6 |
9/30/2024 | 25,791 | 1,986 | 2,170 | 3,723 | N/A |
6/30/2024 | 24,776 | 1,698 | 2,562 | 4,140 | N/A |
3/31/2024 | 23,761 | 1,410 | 2,954 | 4,556 | N/A |
12/31/2023 | 23,326 | 1,332 | 3,051 | 4,613 | N/A |
9/30/2023 | 22,890 | 1,254 | 3,147 | 4,670 | N/A |
3/31/2023 | 18,078 | 1,225 | 2,551 | 3,494 | N/A |
12/31/2022 | 19,414 | 1,265 | 2,654 | 3,839 | N/A |
9/30/2022 | 20,750 | 1,305 | 2,757 | 4,184 | N/A |
3/31/2022 | 27,621 | 1,544 | 2,218 | 4,615 | N/A |
12/31/2021 | 27,340 | 1,606 | 2,731 | 4,879 | N/A |
9/30/2021 | 27,059 | 1,667 | 3,243 | 5,142 | N/A |
3/31/2021 | 24,595 | 629 | 2,678 | 4,128 | N/A |
12/31/2020 | 24,299 | 668 | 2,378 | 4,085 | N/A |
9/30/2020 | 24,003 | 706 | 2,077 | 4,041 | N/A |
6/30/2020 | 25,006 | 1,860 | N/A | N/A | N/A |
3/31/2020 | 26,009 | 3,014 | 2,275 | 4,555 | N/A |
12/31/2019 | 25,957 | 2,792 | 2,435 | 4,605 | N/A |
9/30/2019 | 25,904 | 2,569 | 2,595 | 4,655 | N/A |
6/30/2019 | 25,348 | 1,862 | 2,344 | 4,518 | N/A |
3/31/2019 | 24,792 | 1,155 | 2,093 | 4,380 | N/A |
12/31/2018 | 24,254 | 1,365 | 2,145 | 4,410 | N/A |
9/30/2018 | 23,716 | 1,575 | 2,196 | 4,440 | N/A |
6/30/2018 | 23,184 | 1,511 | N/A | 4,427 | N/A |
3/31/2018 | 22,652 | 1,447 | N/A | 4,413 | N/A |
12/31/2017 | 21,810 | 1,131 | N/A | 4,069 | N/A |
9/30/2017 | 20,967 | 814 | N/A | 3,724 | N/A |
6/30/2017 | 19,656 | 805 | N/A | 3,494 | N/A |
3/31/2017 | 18,345 | 795 | N/A | 3,263 | N/A |
12/31/2016 | 17,456 | 1,206 | N/A | 3,159 | N/A |
9/30/2016 | 16,567 | 1,616 | N/A | 3,055 | N/A |
6/30/2016 | 16,034 | 1,808 | N/A | 3,076 | N/A |
3/31/2016 | 15,500 | 1,999 | N/A | 3,096 | N/A |
12/31/2015 | 15,138 | 1,933 | N/A | 3,024 | N/A |
9/30/2015 | 14,776 | 1,866 | N/A | 2,951 | N/A |
6/30/2015 | 14,379 | 1,830 | N/A | 2,809 | N/A |
3/31/2015 | 13,982 | 1,793 | N/A | 2,667 | N/A |
12/31/2014 | 13,545 | 2,284 | N/A | 2,602 | N/A |
9/30/2014 | 13,107 | 2,774 | N/A | 2,536 | N/A |
6/30/2014 | 12,795 | 2,772 | N/A | 2,642 | N/A |
3/31/2014 | 12,483 | 2,770 | N/A | 2,748 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LHC's forecast earnings growth (7.5% per year) is below the savings rate (9.7%).
Earnings vs Market: LHC's earnings (7.5% per year) are forecast to grow slower than the ZA market (20.3% per year).
High Growth Earnings: LHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: LHC's revenue (5% per year) is forecast to grow faster than the ZA market (4.3% per year).
High Growth Revenue: LHC's revenue (5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LHC's Return on Equity is forecast to be low in 3 years time (17.2%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 16:20 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Life Healthcare Group Holdings Limited is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Rendani Magalela | Absa Bank Limited |
Sean Ungerer | Arqaam Capital Research Offshore S.A.L. |
Simon Mather | Barclays |